Abstract
Gliomas are a group of heterogeneous primary central nervous system tumors arising from glial cells. These tumors are associated with high morbidity and mortality. New opportunities for the development of effective therapies for malignant gliomas are urgently needed. Magnetic nano-particles can heat up tumor tissues and induce the killing of cancer cells. However, the in vivo action of magnetic nano-iron hyperthermia on brain gliomas has not been widely investigated. The safety, efficacy, and suitable dose of hyperthermia therapy remain unknown. We successfully established a rat model of brain glioma by injecting C6 glioma cells into the right caudate nuclei of rats. Fixed doses (2.5, 5, or 10 mg) of magnetic nano-iron were then injected into the tumors of tumor-bearing rats. The survival time of tumor-bearing rats was subsequently observed, and imaging studies were conducted on the brain tumors. Of the 80 rats that underwent C6 glioma cell implantation, 70 exhibited decreased mobility and appetite, and wasting. Establishment of this brain glioma model was confirmed to be successful by magnetic resonance imaging. After injection of different doses of magnetic nano-iron, the survival times of the different dose groups of tumor-bearing rats were not significantly different. However, the tumor size exhibited a significant decrease with magnetic nano-iron hyperthermia therapy. Injection of various doses of magnetic nano-iron was safe in tumor-bearing rats. The effective doses were 2.5 and 5 mg. Magnetic nano-iron hyperthermia significantly shrank the brain gliomas in tumor-bearing rats.
Similar content being viewed by others
References
Central Brain Tumor Registry of the United States (CBTRUS): Statistical report: primary brain tumors in the United States, 2004–2006. Available from: http://www.cbtrus.org/2010-NPCR-SEER/CBTRUS-WEBREPORT-Final-3-2-10.pdf. Accessed August 2, 2010.
Chen L, Miao W, Tang X, et al. The expression and significance of neuropilin-1 (NRP-1) on glioma cell lines and glioma tissues. J Biomed Nanotechnol. 2013;9(4):559–63.
Luptrawan A, Liu G, Yu JS. Dendritic cell immunotherapy for malignant gliomas. Rev Recent Clin Trials. 2008;3(1):10–21.
Wang ZC. Neurosurgery. Hubei Sci Technol Press. 2004;18:518–42.
Cavaliere R, Ciocatto EC, Giovanella BC, et al. Selective heat sensitivity of cancer cells biochemical and clinical studies. Cancer. 1967;20(9):1351–81.
Sellins KS, Cohen JJ. Hyperthermia induces apoptosis in thymocytes. Rad Res. 1991;126(1):88–95.
van der Zee J. Heating the patient: a promising approach? Ann Oncol. 2002;13(8):1173–84.
Coss RA, Linnemans WA. The effects of hyperthermia on the cytoskeleton: a review. Int J Hyperth. 1996;12:173–96.
Lepock JR. Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage. Int J Hyperth. 2003;19:252–66.
Wong RSL, Kapp LN, Krishnaswamy G, Dewey WC. Critical steps for induction of chromosomal aberrations in CHO cells heated in S phase. Radiat Res. 2003;133:52–9.
Yuan XB, Kang CS. Stereotactic injection of drug-loaded nanoparticles targeting capabilities treatment of malignant glioma. Chin J Biomed Eng. 2006;25:765–6.
Yan SY, Zhang DS, Gu N, et al. Fe2O3 nano-magnetic fluid hyperthermia treatment of liver cancer. Chin J Exp Surg. 2004;21:1143.
Ohno T, Wakabayashi T, Takemura A, Yoshida J, Ito A, Shinkai M, et al. Effective solitary hyperthermia treatment of malignant glioma using stick type CMC-magnetite in vivo study. J Neuro-Oncol. 2002;56(3):233–9.
Aandress J. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J Magn Magn Mater. 2001;225:118–26.
Jordan A, Scholz R, Maier-Hauff K, van Landeghem FK, Waldoefner N, Teichgraeber U, et al. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neuro-Oncol. 2006;78(1):7–14.
Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neuro-Oncol. 2007;81(1):53–60.
Shinkai M, Yanase M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study. Jpn J Cancer Res. 1996;87(11):1179–83.
Gneveckow U, Jordan A, Scholz R, Brüss V, Waldöfner N, Ricke J, et al. Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermia. Med Phys. 2004;31(6):1444–51.
Acknowledgments
This work was supported in part by the National Natural Science Foundation of China (81301698).
Author information
Authors and Affiliations
Corresponding author
Additional information
Guo-qing Yi and Bin Gu contributed equally to this work and should be considered as co-first authors.
Rights and permissions
About this article
Cite this article
Yi, Gq., Gu, B. & Chen, Lk. The safety and efficacy of magnetic nano-iron hyperthermia therapy on rat brain glioma. Tumor Biol. 35, 2445–2449 (2014). https://doi.org/10.1007/s13277-013-1324-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-013-1324-8